Reinduction of oxaliplatin-based chemotherapy after exposure to oxaliplatin in adjuvant setting for colorectal cancer.

被引：1
|
作者：
Beom, Seung-Hoon
Ahn, Joong Bae
Shin, Sang Joon
Jung, Minkyu
机构：
[1] Yonsei Canc Ctr, Seoul, South Korea
[2] Yonsei Univ, Dept Internal Med, Canc Metastasis Res Ctr, Yonsei Canc Ctr,Coll Med, Seoul, South Korea
[3] Yonsei Canc Ctr, Sinchon Dong, South Korea
[4] Yonsei Univ, Div Med Oncol, Dept Internal Med, Coll Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.755
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
755
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy
    Seo, An Na
    Kim, Haeryoung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2014, 20 (01) : 81 - 84
  • [42] Splenomegaly during oxaliplatin-based chemotherapy in colon cancer
    Ji, Ruoyu
    Huang, Guanghua
    Liu, Lingshan
    Chen, Mengyin
    Yu, Xiaoduo
    Zhou, Aiping
    Du, Chun-Xia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [43] CAPECITABINE AND OXALIPLATIN (CAPOX) PLUS CETUXIMAB IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA WHO PROGRESSED AFTER OXALIPLATIN-BASED CHEMOTHERAPY
    Petrovic, Z.
    ANNALS OF ONCOLOGY, 2008, 19 : 135 - 135
  • [44] Oxaliplatin-based chemotherapy inpatients with advanced pancreatic cancer
    Vattemi, E.
    Franchi, R.
    Pedersini, R.
    Tansini, G.
    Baier, S.
    Costa, P.
    Signaroldi, A.
    Zanaletti, F.
    Sbalzarini, G.
    Graiff, C.
    ANNALS OF ONCOLOGY, 2006, 17 : 34 - 34
  • [45] Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer
    Izuma Nakayama
    Mitsukuni Suenaga
    Takeru Wakatsuki
    Takashi Ichimura
    Masato Ozaka
    Daisuke Takahari
    Eiji Shinozaki
    Keisho Chin
    Masashi Ueno
    Nobuyuki Mizunuma
    Toshiharu Yamaguchi
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 133 - 139
  • [46] Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer
    Nakayama, Izuma
    Suenaga, Mitsukuni
    Wakatsuki, Takeru
    Ichimura, Takashi
    Ozaka, Masato
    Takahari, Daisuke
    Shinozaki, Eiji
    Chin, Keisho
    Ueno, Masashi
    Mizunuma, Nobuyuki
    Yamaguchi, Toshiharu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 133 - 139
  • [47] Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy
    Souglakos, J.
    Kalykaki, A.
    Vamvakas, L.
    Androulakis, N.
    Kalbakis, K.
    Agelaki, S.
    Vardakis, N.
    Tzardi, M.
    Kotsakis, A. P.
    Gioulbasanis, J.
    Tsetis, D.
    Sfakiotaki, G.
    Chatzidaki, D.
    Mavroudis, D.
    Georgoulias, V.
    ANNALS OF ONCOLOGY, 2007, 18 (02) : 305 - 310
  • [48] Adjuvant chemotherapy in ypStage III locally advanced rectal cancer after neoadjuvant treatment with an oxaliplatin-based regimen
    Cai, Runkai
    Zhang, Jianwei
    Cai, Yue
    Wu, Zehua
    Hu, Huabin
    Xie, Xiaoyu
    Deng, Yanhong
    Cheng, Yi
    Zhang, Yuting
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] Incidence of Cold-Induced Peripheral Neuropathy and Dose Modification of Adjuvant Oxaliplatin-Based Chemotherapy for Patients with Colorectal Cancer
    Altaf, Rahim
    Brixen, Annette Lund
    Kristensen, Bent
    Nielsen, Svend Erik
    ONCOLOGY, 2014, 87 (03) : 167 - 172
  • [50] Sex difference in tolerability of adjuvant oxaliplatin-based chemotherapy for colorectal cancer and changes in diagnostic components of sarcopenia: A prospective study
    Nozawa, Hiroaki
    Abe, Shinya
    Abe, Kentaro
    Yokota, Yumi
    Yakabe, Mitsutaka
    Akishita, Masahiro
    Ishihara, Soichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345